Plexus Corp.'s stock plummeted 11.73% in the pre-market session on Thursday, following the company's disappointing outlook for fiscal year 2025 that missed analyst expectations.
While Plexus reported better-than-expected earnings for the first quarter of fiscal 2025, with adjusted EPS of $1.73 beating the consensus estimate of $1.59, the company's guidance for the second quarter and full year fell short of Wall Street projections.
For the second quarter, Plexus forecasted adjusted earnings of $1.46 to $1.61 per share and revenue of $960 million to $1 billion, lower than analysts' expectations of $1.60 adjusted EPS and $1.02 billion revenue. The company also reported weakness in the Healthcare/Life Sciences and Aerospace/Defense sectors, which impacted its first-quarter revenue.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。